Agebox Recalls iKids-Growth Capsules Due to Undeclared Ibutamoren
Agebox is voluntarily recalling 665 bottles of iKids-Growth (Day Formula) capsules because they contain undeclared ibutamoren and were marketed without FDA approval.
What Happened
Agebox has initiated a voluntary recall of its iKids-Growth (Day Formula) capsules. The recall was triggered because the product contains undeclared ibutamoren and is being marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). The FDA has classified this as a Class II recall.
Which Products Are Affected
The recall affects 665 bottles of Agebox iKids-Growth (Day Formula), 60-count bottles. The products are labeled as “Manufactured Exclusively For: AGEBOX Inc., Wilmington, DE 19801 USA.”
Product Details:
- UPC: 8 50065 59701 0
- Lot # 23101201 (Expiration: 09/2026)
- Lot # 24080801 (Expiration: 07/2027)
- Lot # 25020701 (Expiration: 01/2028)
These products were distributed nationwide across the United States through Agebox.com (via Shopify) and Amazon.com. All orders were shipped directly to customers by Agebox.
What You Should Do
Consumers who have purchased the affected lots of iKids-Growth (Day Formula) should stop using the product immediately. For further information regarding returns or questions about the recall, consumers may contact Agebox at their Wilmington, Delaware headquarters. The firm initially notified customers of the recall via e-mail on October 28, 2025.
Why This Matters
The presence of undeclared pharmaceutical ingredients like ibutamoren in a dietary supplement poses potential health risks to consumers. Furthermore, marketing such products without required FDA approvals violates federal safety regulations designed to ensure drug efficacy and safety.
Source
FDA (Recall Number: D-0344-2026)
Source: FDA Official Notice